Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.

Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001193125-26-059532 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-02-19	2026-02-17	KMTS	Webster Brian Daniel	See Remarks, Dir	S - Sale	$25.60	-15.0K	383.2K	-4%	-$384.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2026-02-17	S	D	3,272	$26.29	379,879	D	—	—	(F3) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.0200 to $26.9998. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
2	Common	Common Shares	2026-02-17	S	D	93	$27.18	379,786	D	—	—	(F4) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.0771 to $27.1800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
3	Common	Common Shares	2026-02-17	S	D	11,635	$25.39	383,151	D	—	—	(F2) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.0150 to $26.0100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.